Active Ingredient(s):Rotigotine FDA Approved: * May 9, 2007 Pharm Company: *SCHWARZ Category:Parkinsons
Rotigotine, sold under the brand name Neupro among others, is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS). It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.
Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and ...
* May have multiple approval dates, manufacturers, or labelers.